Trials / Completed
CompletedNCT02961673
The Safety and Efficacy Study of HU-014 Versus Botox® in Subject With Moderate to Severe Glabellar Lines
A Phase I/Ⅱ Clinical Trial to Compare the Safety and Efficacy of HU-014 Versus Botox® in Subject With Moderate to Severe Glabellar Lines
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 57 (actual)
- Sponsor
- Huons Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
A Phase I/Ⅱ Clinical Trial to Compare the Safety and Efficacy of HU-014 versus Botox® in Subject with Moderate to Severe Glabellar Lines
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | HU-014 Inj | Clostridium botulinum type A |
| BIOLOGICAL | Botox Inj | Clostridium botulinum type A |
Timeline
- Start date
- 2016-09-01
- Primary completion
- 2017-02-01
- Completion
- 2017-03-01
- First posted
- 2016-11-11
- Last updated
- 2018-04-12
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02961673. Inclusion in this directory is not an endorsement.